The Patent Finder

Prostate Stem Cell Antigen (PSCA) Variants and Subsequences Thereof

Agensys, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,622,564Prostate Stem Cell Antigen (PSCA) Variants and Subsequences Thereof
In force
 · High confidence
Agensys, Inc.In force
High confidence
US 7,595,379Antibodies and Related Molecules That Bind to Psca Proteins
Lapsed Sep 29, 2017 on the fee record
Ended Sep 29, 2017 · High confidence
Agensys, Inc.Lapsed Sep 29, 2017 on the fee recordEnded Sep 29, 2017
High confidence
US 7,541,442Antibodies and Related Molecules That Bind to Psca Proteins
Term ended
Term ended May 28, 2024 · High confidence
Agensys, Inc.Term endedTerm ended May 28, 2024
High confidence
US 8,278,424Antibodies That Bind to Psca Proteins for Diagnosis of Cancer
Term ended
Term ended May 28, 2024 · Medium confidence
Agensys, Inc.Term endedTerm ended May 28, 2024
Medium confidence
US 8,853,364Prostate Stem Cell Antigen (PSCA) Variants and Subsequences Thereof
Term ended · USPTO later recorded non-payment Nov 9, 2026
Term ended May 28, 2024 · High confidence
Agensys, Inc.Term ended
USPTO later recorded non-payment Nov 9, 2026
Term ended May 28, 2024
High confidence
US 8,013,128Antibodies and Related Molecules That Bind to Psca Proteins
Term ended
Ended no later than Oct 11, 2024 · Medium confidence
Agensys, Inc.Term endedEnded no later than Oct 11, 2024
Medium confidence
US 8,206,932Antibodies and Related Molecules That Bind to Psca Proteins
Term ended
Ended no later than Apr 7, 2025 · Medium confidence
Agensys, Inc.Term endedEnded no later than Apr 7, 2025
Medium confidence
Application 13/631,699Antibodies That Bind to Psca Proteins for Diagnosis of Cancer
Abandoned
Abandoned Dec 17, 2014
Agensys, Inc.AbandonedAbandoned Dec 17, 2014
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Agensys, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited